Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Dyspareunia and psychosexual support
Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Sex-associated pain can reveal urgent disease or harm
Sudden severe pelvic pain, collapse, heavy bleeding, fever, pregnancy-related pain, significant genital trauma, sexual assault, coercion or immediate safeguarding danger requires an acute medical and safety response rather than routine psychosexual advice.
Action: Assess physical stability and pregnancy risk, treat injury or infection, preserve choice about forensic and sexual-assault services, speak privately, document carefully and activate emergency or safeguarding pathways with the person's safety and consent central wherever legally possible.
Overview
Assess pain during or after sexual activity without assumptions or coercion, identify superficial and deep contributors, and combine cause-specific, pelvic-floor and psychosexual support around the person's goals.
Dyspareunia is pain experienced during or after sexual activity. It may be provoked at the vulva or vaginal entrance, occur with deeper penetration, persist afterwards or arise with non-sexual insertion such as tampons or examinations. Some people also experience involuntary pelvic-floor tightening and marked fear or avoidance around anticipated penetration. Use the person's own anatomy, language, sexual practices and goals. The clinical aim is comfortable, consensual intimacy as defined by them, not successful penetration as a universal outcome.
Begin with permission: explain that sexual pain is common enough to discuss, ask whether now is a safe time and offer a private consultation. Map primary pain present from first attempted insertion versus acquired pain after a pain-free period; situational versus generalised triggers; superficial versus deep location; burning, tearing, aching or cramping quality; and duration after contact. Ask what types of touch, positions, depth, arousal and lubricants change the symptom, without assuming a partner's gender or activity.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
Examination when penetration is painful
A 24-year-old with painful attempted penetration becomes visibly tense when a speculum examination is suggested and says she is not ready. What is the best next step?
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
The associated history identifies causes. Discharge, odour, itch, ulceration and STI exposure support infection or vulval disease. Dryness can accompany menopause, lactation, pregnancy, hormonal treatments, antidepressants and inadequate arousal. Cyclical deep pain, dysmenorrhoea and painful defecation suggest endometriosis; heavy painful periods and a bulky uterus suggest adenomyosis. Urinary urgency, bladder-filling pain, constipation and bowel symptoms can refer into sex. Birth trauma, surgery, radiotherapy and female genital mutilation can alter tissue and muscle function.
Ask about desire, arousal, orgasm, relationship communication, body image, mood, past painful encounters and the impact on intimacy. Enquire privately about coercion, assault and current safety without making disclosure a condition of care. Trauma can shape autonomic threat and examination tolerance, but must not be presumed or presented as the cause. Conversely, a physical diagnosis does not remove the need to address fear, avoidance or relationship strain created by repeated pain.
Examination is negotiated in advance and can occur over several visits. Inspect the vulva for fissures, inflammation, discharge, scarring, dermatosis, atrophy and suspicious lesions. Gentle cotton-swab mapping can locate provoked vestibular pain. A small speculum may assess vaginal tissue, discharge and cervix if relevant; single-digit palpation can assess pelvic-floor resting tone, tenderness and ability to contract and relax before any bimanual examination. The patient controls pace and can stop at any point. A chaperone is offered, and self-insertion of a speculum or mirror may help some people.
Testing follows findings. Pregnancy testing matters with pregnancy potential and pain or bleeding. Take vaginal or cervical samples when infection is plausible and offer STI testing according to exposure. Examine and biopsy persistent or suspicious vulval lesions through an experienced service rather than treating repeatedly as candidiasis. Cervical and endometrial pathways address abnormal bleeding. Pelvic ultrasound assesses masses, adenomyosis and endometriomas, while normal imaging does not exclude superficial endometriosis or pelvic-floor pain.
Initial supportive care can begin before every diagnosis is complete. Advise stopping painful activity rather than pushing through, allow arousal time and use a simple fragrance-free water- or silicone-based lubricant compatible with condoms and devices. Regular vaginal moisturisers differ from lubricants used during activity. Explore positions, depth control, external touch and non-penetrative intimacy. These measures are options, not instructions to resume activity before the person feels safe and ready.
For genitourinary symptoms associated with menopause, NICE recommends offering vaginal oestrogen and explaining that systemic absorption is minimal compared with systemic HRT, serious adverse effects are very rare and symptoms often recur after stopping. Choose cream, gel, tablet, pessary or ring with the patient and combine with moisturiser or lubricant if useful. In someone with personal breast-cancer history, start with non-hormonal moisturisers or lubricants; consider vaginal oestrogen for persistent symptoms, and work with the breast-cancer specialist when an aromatase inhibitor is being used.
Pelvic-health physiotherapy is appropriate for overactivity, tenderness or poor relaxation. Assessment may include breathing, down-training, manual techniques, bowel and bladder mechanics and a graded home programme. Generic repeated Kegel contraction can worsen an already overactive floor, so training must be tailored. Vaginal trainers or dilators can be introduced gradually by the patient with lubricant and complete control, never forced by a partner or clinician and never used as a test of compliance.
Psychosexual therapy addresses the pain–fear–guarding–avoidance cycle, sexual communication, arousal, desire, body image and alternative pleasurable intimacy. Therapy may be individual or couple-based, but partner involvement requires consent and is inappropriate when coercion or abuse is present. Pain-focused psychological approaches can help threat regulation without implying a psychogenic origin. Combine these with cause-specific treatment rather than waiting for one domain to be completed first.
Follow-up measures what the person values: reduced anticipatory fear, comfortable examination, enjoyable non-penetrative contact, improved lubrication, less post-activity pain or desired penetration. Re-examine only when it will change care. Refer to vulval dermatology, sexual health, menopause, endometriosis, pelvic pain, pelvic-health physiotherapy or accredited psychosexual services according to the formulation. New bleeding, lesion, systemic illness or acute pain reopens medical investigation.
Key points
Dyspareunia means pain during or after sexual activity; describe the site and trigger rather than assuming penile–vaginal intercourse, heterosexuality, relationship status or that penetration is the desired goal.
Superficial or insertional pain points toward dryness, genitourinary syndrome of menopause, infection, vulval dermatosis, vestibulodynia, trauma or pelvic-floor overactivity; deep pain raises endometriosis, adenomyosis, PID, masses, bowel, bladder or pelvic-floor causes.
Ask about onset, arousal and lubrication, exact touch or depth trigger, persistence after activity, cycle, discharge, bleeding, urinary and bowel symptoms, childbirth, menopause, medicines and what forms of intimacy the person wants to preserve.
Psychological and relational factors can amplify a real pain response, while repeated pain can create fear, muscle bracing and avoidance; neither direction means that symptoms are imagined.
Examination is optional, staged and consented: inspect when useful, use a gentle cotton-swab or single-digit pelvic-floor assessment only with agreement, and defer speculum or bimanual examination when distress or pain outweighs immediate value.
Treat identifiable infection, skin disease, endometriosis, adenomyosis or menopause-related atrophy and use pelvic-health physiotherapy for overactive muscles, emphasising relaxation and coordination rather than unsupervised strengthening.
Aetiology
01
Superficial tissue causes
Oestrogen deficiency, infection, vulval dermatoses, fissures, trauma, scarring and provoked vestibulodynia create pain at the vulva or entrance with touch and friction.
02
Deep pelvic causes
Endometriosis, adenomyosis, pelvic inflammatory disease, ovarian or uterine masses, bladder and bowel disease and adhesions can hurt with depth or afterwards.
03
Neuromuscular and contextual causes
Pelvic-floor overactivity, nerve sensitisation, fear, previous painful encounters, trauma, low arousal, medicine effects and relationship context can contribute alone or with tissue disease.
Pathophysiology
1
Friction and tissue fragility
Reduced lubrication or thin inflamed epithelium increases shear and microtrauma, producing burning, splitting and anticipatory pain during subsequent contact.
2
Protective muscle response
Expected pain activates involuntary pelvic-floor contraction; sustained guarding causes muscle fatigue, trigger points, difficult insertion and further nociceptive input.
3
Peripheral and central sensitisation
Repeated inflammation or painful contact lowers sensory thresholds, allowing light touch or ordinary pressure to be processed as burning or sharp pain.
4
Pain–fear–avoidance loop
Pain increases threat and reduces arousal and lubrication, avoidance strains intimacy, and later attempts occur with greater vigilance and guarding unless the cycle is interrupted safely.
Clinical features and red flags
Superficial tissue pain
Burning, splitting or raw pain at initial contact with dryness, fissures, pale atrophic tissue, discharge or visible skin change points to local tissue disease.
Provoked vestibular pain
Normal-looking skin with reproducible focal pain to light touch at the vestibule supports vestibulodynia after infection, dermatosis and other causes are excluded.
Pelvic-floor overactivity
Involuntary tightening, difficult insertion, urinary or bowel emptying symptoms and tender muscles that cannot relax indicate a neuromuscular contributor rather than obstruction by anatomy alone.
Deep pelvic pain
Pain with depth or persisting after activity, especially with dysmenorrhoea, bowel, bladder or bleeding symptoms, supports endometriosis, adenomyosis, PID or another pelvic disorder.
Threat and avoidance cycle
Anticipatory fear increases autonomic arousal and muscle guarding, pain confirms the threat and avoidance follows; each component is treatable without denying physical pathology.
Red flags requiring action
Syncope, peritonism, heavy bleeding or acute unilateral pain with vomiting needs urgent assessment for ectopic pregnancy, torsion, cyst rupture, trauma or another surgical emergency.
Fever, offensive discharge, pelvic tenderness or systemic illness raises pelvic inflammatory disease, abscess or infection and should not be managed with lubricant advice alone.
Investigations
01Pregnancy and infection testingFirst step
Why
Identify pregnancy-related pain and sample vaginal, cervical or urinary infection when symptoms, examination or exposure make it plausible.
Interpretation and limitations
A positive pregnancy test with pain or bleeding needs location assessment. Negative swabs do not explain pain and should prompt review of tissue, pelvic-floor and deeper causes.
02Vulval inspection and selective biopsy
Why
Identify atrophy, fissures, infection, lichen sclerosus or planus, scarring and suspicious vulval lesions.
Interpretation and limitations
Biopsy a persistent or atypical lesion through an appropriate service; normal appearance can coexist with provoked vestibulodynia and does not invalidate touch-evoked pain.
03Cotton-swab and pelvic-floor assessment
Why
Map superficial allodynia and assess muscle resting tone, tenderness, coordination and relaxation with explicit consent.
Interpretation and limitations
Findings guide desensitisation and physiotherapy but are not compulsory; stop when requested and avoid interpreting distress as diagnostic resistance.
04Pelvic ultrasound
Why
Assess ovarian masses, endometriomas, adenomyosis, fibroids and other structural explanations for deep dyspareunia.
Interpretation and limitations
Differential diagnosis
01
Genitourinary syndrome of menopause
Dryness, pale fragile tissue, urinary symptoms and pain with sex after oestrogen decline supports local atrophy, while bleeding still needs appropriate assessment.
02
Infection or dermatosis
Discharge, odour, itch, fissure, erosion, pigment or architectural change suggests candidiasis, STI or vulval skin disease requiring examination and targeted tests.
03
Vulvodynia or vaginismus
Provoked pain with normal-appearing skin and involuntary tightening or fear around insertion supports sensory and pelvic-floor disorders after other causes are excluded.
04
Endometriosis or adenomyosis
Deep cyclical pain, dysmenorrhoea, painful defecation, heavy bleeding or a bulky uterus shifts attention to pelvic disease that routine vulval care will not treat.
05
Bladder, bowel or musculoskeletal pain
Bladder filling, constipation, bowel inflammation, hip pathology and pelvic-floor trigger points can be provoked by sexual position and mimic gynaecological depth pain.
Management
01First conversationName the pain and protect autonomyFirst stepA person reports pain during or after sexual activity or difficulty with desired penetration.+
1Ask permission, speak privately and clarify site, trigger, timing, associated symptoms, desired activities, impact and immediate safety without assumptions about partners or practices.
2Explain possible tissue, infection, pelvic, muscle, nerve and threat-response contributors and agree whether examination now, later or not at all is most useful.
3Offer immediate non-painful intimacy and lubricant strategies and give urgent return advice for bleeding, fever, pregnancy-related symptoms or acute severe pain.
02Cause-specific routeTreat tissue and pelvic diseaseHistory, examination or tests identify atrophy, infection, dermatosis, endometriosis, adenomyosis or another medical cause.+
1Treat the identified condition with its current guideline and review whether superficial, deep and post-activity pain respond in the expected way.
Complications
01
Avoidance and loss of intimacy
Repeated pain can lead to fear, reduced arousal, avoidance of touch, loss of desired sexual expression and distress for the person and relationship.
02
Pelvic-floor dysfunction
Persistent guarding can impair penetration, examination, urination and defecation and maintain pain even after the original tissue trigger is treated.
03
Delayed underlying diagnosis
Embarrassment or premature psychologising can delay recognition of endometriosis, vulval disease, infection, menopause-related atrophy, trauma or malignancy.
04
Psychological distress
Pain, invalidation, fertility concerns and relationship strain can contribute anxiety, low mood, shame and trauma symptoms requiring support without blame.
Monitoring and follow-up
Review the outcomes chosen by the person, such as less burning, reduced post-activity pain, comfortable examination, lower fear or return to desired intimacy.
Check response and adverse effects after infection, dermatosis, endometriosis, menopause or other cause-specific treatment and reconsider the diagnosis when the expected domain does not improve.
For vaginal oestrogen, review symptom control, any new bleeding and ongoing preference; symptoms can recur after stopping and treatment can be restarted when appropriate.
Pelvic-health physiotherapy should document resting tone, relaxation, functional goals and flare response rather than progression based only on trainer size.
Repeat private safeguarding enquiry when circumstances change and maintain a direct route back for new lesions, bleeding, fever, pregnancy concern or sudden deep pain.
Special situations
Location directs the differential
Pain at first touch and pain with depth are not mutually exclusive, but separating them prevents vulval disease from being hidden by a pelvic diagnosis or vice versa.
Normal skin can be painful
Provoked vestibulodynia and sensitised pelvic-floor pain may have no visible lesion, so examination must include gentle functional assessment rather than visual dismissal.
Relaxation can precede strengthening
A pelvic floor held at high resting tone may need down-training and coordination before strengthening; generic contractions can aggravate pain and emptying symptoms.
Therapy is not a psychogenic verdict
Psychosexual work targets fear, communication, arousal and the consequences of pain while medical causes continue to receive active treatment.
Penetration is not the endpoint
Successful care is defined by the patient's values, which may centre comfort, pleasure, intimacy, examination tolerance or safety without penetrative activity.
Common pitfalls
01
Assuming dyspareunia means penile–vaginal intercourse or that penetrative sex is the patient's desired treatment goal.
02
Performing a speculum or bimanual examination without explaining its purpose, obtaining ongoing consent and offering to stop.
03
Treating repeatedly for candidiasis without microbiological or examination support while missing dermatosis, vestibulodynia or pelvic-floor pain.
04
Prescribing pelvic-floor strengthening exercises to someone whose primary problem is overactivity and impaired relaxation.
05
Using psychosexual referral as a way to discharge unexplained pain from medical care.
06
Inviting a partner into assessment before private safeguarding enquiry or without the patient's explicit agreement.
NICE recommends vaginal oestrogen for menopause-associated genitourinary symptoms and allows it with moisturisers or lubricants; people with breast-cancer history start with non-hormonal options and need individual specialist-informed decisions when symptoms persist.
Psychosexual therapy can rebuild safety, communication, desire and pleasurable non-painful intimacy; involve a partner only with the patient's agreement and never frame penetration as a compulsory treatment endpoint.
A persistent vulval ulcer, architectural change, pigment change, induration, unexplained bleeding or mass requires specialist examination and possible biopsy for dermatosis, intraepithelial neoplasia or cancer.
Postcoital or postmenopausal bleeding requires cervical, vaginal and endometrial assessment according to age and risk, even when vaginal dryness is present.
Fear, controlling behaviour, inability to negotiate sexual activity, injury, reproductive coercion or disclosure of assault requires private enquiry and an immediate person-centred safeguarding response.
A normal scan does not exclude superficial endometriosis, vulvodynia, bladder pain, bowel disease or pelvic-floor overactivity.
05Abnormal-bleeding assessment
Why
Evaluate postcoital, intermenstrual or postmenopausal bleeding through cervical, vaginal and endometrial pathways.
Interpretation and limitations
Dry atrophic tissue may bleed, but visible lesions and age- or risk-specific cancer assessment must be completed before reassurance.
2For menopause-associated genitourinary symptoms, offer vaginal oestrogen or non-hormonal moisturiser and lubricant according to preference and cancer history.
3Refer suspicious lesions, deep endometriosis, persistent infection, abnormal bleeding or a pelvic mass to the appropriate specialist rather than repeating empirical treatment.
03Pelvic-floor routeRestore relaxation and controlMuscle overactivity, tenderness, involuntary tightening or difficult insertion contributes to pain.+
1Refer to a pelvic-health physiotherapist who can assess contraction and relaxation and tailor down-training, breathing, manual and functional work.
2Use graded touch or vaginal trainers only if the patient chooses, starting below the pain threshold with lubricant, privacy and complete control over progression.
3Avoid painful repeated penetration, forced examination and unsupervised strengthening that increases resting tone; reassess tissue and deeper causes if progress stalls.
04Psychosexual routeRebuild safety, pleasure and communicationFear, avoidance, altered arousal, relationship strain or loss of desired intimacy persists with or without physical disease.+
1Offer a trained psychosexual therapist or pain-informed psychological practitioner and explain that therapy complements rather than disproves physical treatment.
2Set goals defined by the patient, including non-penetrative pleasure, reduced fear, communication, examination tolerance or desired penetration without making any one goal compulsory.
3Invite a partner only with explicit agreement, screen for coercion first and use individual safeguarding and support when the relationship is unsafe.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
A local oestrogen option for vaginal atrophy due to postmenopausal oestrogen deficiency causing dryness, tissue fragility and pain with sex.
Estradiol 10 microgram vaginal tablet
Insert one 10 microgram vaginal tablet once daily for 2 weeks, then continue one tablet twice weekly as maintenance; treatment may begin on any convenient day.
Assess unexplained vaginal bleeding and product contraindications, treat vaginal infection first and review regularly. With personal breast-cancer history, start with non-hormonal measures and individualise persistent symptoms; involve the breast specialist for current aromatase-inhibitor treatment.